Generex expands Glucose RapidSpray distribution

26 February 2007

Generex Biotechnology, a Canadian firm focused on drug delivery for metabolic diseases through the inner lining of the mouth, has expanded distribution of Glucose RapidSpray, its proprietary buccal glucose spray product.

The product is now available in over 2,500 stores in the USA at Aurora Pharmacy, Bi-Mart, The Diabetes Place, Fruth Pharmacy, Hy-Vee, Kerr Drug, The Medicine Shoppe Pharmacy, Meijer and ShopKo Stores. The product is also available for purchase on-line at www.GlucoseRapidSpray.com and www.DiabeticExpress.com.

Generex notes that Glucose RapidSpray is an innovative alternative for people who want additional glucose in their diet. It delivers a fat-free, low-calorie glucose formulation developed using the company's proprietary buccal drug delivery technologies, and is easy to carry and use.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >

Today's issue

Company Spotlight

Ironwood is a US-based biotech advancing a pipeline of medicines in multiple areas of significant unmet need, including irritable bowel syndrome with constipation ((IBS-C)/chronic idiopathic constipation (CIC), vascular and fibrotic diseases, and refractory gastroesophageal reflux disease, among others.